BridgeBio Pharma (BBIO) Intangibles (2021 - 2025)
Historic Intangibles for BridgeBio Pharma (BBIO) over the last 6 years, with Q3 2025 value amounting to $28.8 million.
- BridgeBio Pharma's Intangibles rose 1741.08% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 1741.08%. This contributed to the annual value of $23.9 million for FY2024, which is 909.23% down from last year.
- According to the latest figures from Q3 2025, BridgeBio Pharma's Intangibles is $28.8 million, which was up 1741.08% from $29.5 million recorded in Q2 2025.
- BridgeBio Pharma's Intangibles' 5-year high stood at $46.2 million during Q3 2021, with a 5-year trough of $23.9 million in Q4 2024.
- Moreover, its 5-year median value for Intangibles was $28.1 million (2023), whereas its average is $29.6 million.
- As far as peak fluctuations go, BridgeBio Pharma's Intangibles tumbled by 3656.39% in 2022, and later soared by 1747.4% in 2025.
- Quarter analysis of 5 years shows BridgeBio Pharma's Intangibles stood at $44.9 million in 2021, then crashed by 36.1% to $28.7 million in 2022, then fell by 8.33% to $26.3 million in 2023, then decreased by 9.09% to $23.9 million in 2024, then grew by 20.35% to $28.8 million in 2025.
- Its Intangibles was $28.8 million in Q3 2025, compared to $29.5 million in Q2 2025 and $27.8 million in Q1 2025.